Boundless Bio, Inc.
BOLDNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $52.98M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.96$3.16
- Volume (live)
- -
- Avg. volume (3M)
- 175.46K
Boundless Bio (BOLD) Stock Price & Financial Analysis
Boundless Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.35 - $2.44 |
|---|---|
| 52-Week High | $3.16 |
| 52-Week Low | $0.96 |
| Open | $2.41 |
| Volume (last close) | 34.87K |
| Average Volume (3M) | 175.46K |
| 50-Day MA | $2.72 |
|---|---|
| 200-Day MA | $1.87 |
| 1-Year Change | +73.05% |
| Market Cap | 52.98M |
|---|---|
| Shares Outstanding | 22.45M |
| Price to Book (P/B) | 0.80 |
| EV/EBITDA | -0.54 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Boundless Bio at a Glance
As of the Oct 23, 2026 close, Boundless Bio (BOLD) has a market capitalization of $52.98M.
As of its latest reported balance sheet, it holds $20.21M in cash and securities against $0.00 of debt, a net cash position of $20.21M.
Boundless Bio does not currently pay a dividend.
The share price is up 73.0% over the past year. At $2.36 (the Oct 23, 2026 close) it sits within its 52-week range of $0.96 to $3.16, above its 200-day moving average of $1.86.
Frequently Asked Questions About Boundless Bio
What is the current stock price for BOLD?
As of the Oct 23, 2026 close, BOLD stock trades at $2.36. The 52-week range is $0.96–$3.16, with a day range of $2.35–$2.44.
What is the P/E ratio for BOLD?
The P/E ratio (Price-to-Earnings) for BOLD is shown in the Key Statistics section. This valuation metric helps compare Boundless Bio, Inc. to industry peers.
Does BOLD pay dividends?
Boundless Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BOLD?
Analyst ratings and recommendations for BOLD are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of BOLD?
As of the Oct 23, 2026 close, Boundless Bio's market capitalization is $53.0M, classifying it as a micro-cap company. Boundless Bio operates in the Healthcare sector within the Biotechnology industry.